FDA Approves New Drug for Traveler ' s Diarrhea (Aemcolo) FDA Approves New Drug for Traveler ' s Diarrhea (Aemcolo)

Aemcolo (rifamycin) is indicated to treat adults with travelers ' diarrhea caused by noninvasive strains of E. coli and not complicated by fever or blood in the stool.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news